Candel Therapeutics Inc.

NASDAQ: CADL · Real-Time Price · USD
6.04
0.49 (8.83%)
At close: Jun 06, 2025, 3:59 PM
6.01
-0.50%
Pre-market: Jun 09, 2025, 04:01 AM EDT
8.83%
Bid 5.82
Market Cap 302.62M
Revenue (ttm) n/a
Net Income (ttm) -39.58M
EPS (ttm) -1.33
PE Ratio (ttm) -4.54
Forward PE -4.32
Analyst Buy
Ask 6.04
Volume 1,091,291
Avg. Volume (20D) 993,771
Open 5.60
Previous Close 5.55
Day's Range 5.56 - 6.20
52-Week Range 3.79 - 14.60
Beta -0.87

About CADL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CADL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CADL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
+6.07%
Shares of Candel Therapeutics are trading higheraf... Unlock content with Pro Subscription
1 month ago
+0.42%
Candel Therapeutics shares are trading higher after the company announced the oral pretension of its Phase 3 CAN-2409 results in localized prostate cancer at ASCO 2025.